Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 52, n° 3S
page P2 (mars 2005)
Doi : 10.1016/j.jaad.2004.10.022
Adalimumab in psoriatic arthritis: 24-week results of a phase III study

Philip Mease, MD, University of Washington School of Medicine, Seattle, WA, United States; Dafna Gladman, MD, University of Toronto, Toronto, ON, Canada; Christopher Ritchlin, MD, University of Rochester, Rochester, NY, United States; Mark Weinberg, MD, Abbott Laboratories, Abbott Park, IL, United States

Financial relationships with Abbott Laboratories: Dr. Mease writes research grants, receives consulting fees, and in on the Abbott Laboratories speaker's bureau. Dr. Gladman is a clinical investigator for and it on the advisory board of Abbott Laboratories. Dr. Ritchlin writes research grants for Abbott Laboratories. Dr. Weinberg is employed by Abbott Laboratories.
Abbott Laboratories supported this study and the printing of this poster.

Top of the page

© 2005  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline